✦ LIBER ✦

L-Dopa Therapy Combined with Peripheral Decarboxylase Inhibitor (MK-486) in Parkinsonism

✍ Scribed by Takashi Ohmoto; Hidemi Kishikawa

Book ID: 118707371
Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 643 KB
Volume: 29
Category: Article
ISSN: 1323-1316
DOI: 10.1111/j.1440-1819.1975.tb02318.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of deterioration in long-term trea

Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitor

✍ H. P. Ludin; F. Bass-Verrey 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 602 KB

Levodopa alone and in combination with a

Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (madopar®) in the treatment of Parkinson's disease

✍ U. K. Rinne; E. Birket-Smith; E. Dupont; E. Hansen; M. Hyyppä; R. Marttila; B. M 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 528 KB

A combination of levodopa and the extracerebrally acting decarboxylase inhibitor benserazide (ratio 4:1) (Madopar), was compared with levodopa alone in a controlled double-blind clinical multicenter trial on 94 patients with Parkinson's disease. During 4 months of therapy levodopa + benserazide prov

Effect of a slow release preparation of

Effect of a slow release preparation of levodopa on Parkinson's disease in combination with a peripheral decarboxylase inhibitor

✍ A. Saarinen; V. V. Myllylau; O. Tokola; E. Hokkanen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Improvement of both psychotic symptoms a

Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and l-DOPA

✍ Kimiyasu Kato; Tadashi Wada; Shinobu Kawakatsu; Koichi Otani 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB